Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: Implications for monotherapy and combination treatment

Roderich E. Schwarz, Cecile A. Donohue, David Sadava, Susan E. Kane

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

One of the greatest challenges in the treatment of pancreatic cancer remains its inherent lack of beneficial response to cytotoxic chemotherapy. Chinese herbal extracts have been widely used for the treatment of various cancers, but objective information on their efficacy in pancreatic cancer is lacking. Eight human pancreatic cancer cell lines (MIA, Panc-1, BxPC, ASPC, HS-766T, CaPan-2, CFPAC, and HTB-147) were studied for in vitro susceptibility to ethanol extracts of SPES and PC-SPES, two quality-controlled, dried, encapsulated supplements of 15 and eight Chinese herbs, respectively. Resulting toxicities, alone and in combination with doxorubicin or gemcitabine, were analyzed by [3H]thymidine incorporation or sulforhodamine B staining, colony formation, and TUNEL flow cytometry assays. Combination toxicity mechanisms were calculated by the combination index method of Chou and Talalay. In all cell lines, there was dose-dependent inhibition of proliferation. By [3H]thymidine incorporation assay, 50% growth inhibition after 48 h continuous exposure (IC50) occurred at concentrations of 0.2-0.8 μl/ml SPES and 0.4-1.3 μl/ml PC-SPES. Growth inhibition was accompanied by a significant enhancement of the TUNEL-positive apoptotic fraction of all cell lines after treatment with either extract. After treatment with PC-SPES, the cell lines consistently displayed a G2 cell cycle block; SPES induced an increase in S phase, with a smaller impact on G2. When added at a concentration of 0.2 μl/ml (∼IC20), both extracts enhanced Panc-1 cell killing mediated by doxorubicin, with an average decrease in the corresponding IC50 of 33% (range 11-62%). Combination effects with either extract appeared to be antagonistic in the case of gemcitabine and additive to mildly synergistic in the case of doxorubicin. Both SPES and PC-SPES exhibited significant toxicity in pancreatic cancer cells, mediated via induction of apoptosis. Both mixtures should be evaluated for their in vivo and clinical therapeutic utility as monotherapy agents against pancreatic cancer. SPES could possibly be combined with cell cycle-independent cytotoxic drugs. Due to a consistent G2 blocking pattern, PC-SPES may prove useful as a radiation sensitizer.

Original languageEnglish (US)
Pages (from-to)59-68
Number of pages10
JournalCancer Letters
Volume189
Issue number1
DOIs
StatePublished - Jan 10 2003

Fingerprint

Pancreatic Neoplasms
gemcitabine
Doxorubicin
Cell Line
In Situ Nick-End Labeling
lissamine rhodamine B
Thymidine
Inhibitory Concentration 50
Cell Cycle
Radiation-Sensitizing Agents
Therapeutics
Growth
S Phase
Flow Cytometry
Ethanol
herbal preparation PC-SPES
In Vitro Techniques
Apoptosis
Staining and Labeling
Drug Therapy

Keywords

  • Chinese herbal supplements
  • Combination toxicity
  • Pancreatic cancer
  • PC-SPES
  • SPES
  • Synergism

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES : Implications for monotherapy and combination treatment. / Schwarz, Roderich E.; Donohue, Cecile A.; Sadava, David; Kane, Susan E.

In: Cancer Letters, Vol. 189, No. 1, 10.01.2003, p. 59-68.

Research output: Contribution to journalArticle

Schwarz, Roderich E. ; Donohue, Cecile A. ; Sadava, David ; Kane, Susan E. / Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES : Implications for monotherapy and combination treatment. In: Cancer Letters. 2003 ; Vol. 189, No. 1. pp. 59-68.
@article{14a6a1bcde6d4831b3ff41f53ba6e18e,
title = "Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: Implications for monotherapy and combination treatment",
abstract = "One of the greatest challenges in the treatment of pancreatic cancer remains its inherent lack of beneficial response to cytotoxic chemotherapy. Chinese herbal extracts have been widely used for the treatment of various cancers, but objective information on their efficacy in pancreatic cancer is lacking. Eight human pancreatic cancer cell lines (MIA, Panc-1, BxPC, ASPC, HS-766T, CaPan-2, CFPAC, and HTB-147) were studied for in vitro susceptibility to ethanol extracts of SPES and PC-SPES, two quality-controlled, dried, encapsulated supplements of 15 and eight Chinese herbs, respectively. Resulting toxicities, alone and in combination with doxorubicin or gemcitabine, were analyzed by [3H]thymidine incorporation or sulforhodamine B staining, colony formation, and TUNEL flow cytometry assays. Combination toxicity mechanisms were calculated by the combination index method of Chou and Talalay. In all cell lines, there was dose-dependent inhibition of proliferation. By [3H]thymidine incorporation assay, 50{\%} growth inhibition after 48 h continuous exposure (IC50) occurred at concentrations of 0.2-0.8 μl/ml SPES and 0.4-1.3 μl/ml PC-SPES. Growth inhibition was accompanied by a significant enhancement of the TUNEL-positive apoptotic fraction of all cell lines after treatment with either extract. After treatment with PC-SPES, the cell lines consistently displayed a G2 cell cycle block; SPES induced an increase in S phase, with a smaller impact on G2. When added at a concentration of 0.2 μl/ml (∼IC20), both extracts enhanced Panc-1 cell killing mediated by doxorubicin, with an average decrease in the corresponding IC50 of 33{\%} (range 11-62{\%}). Combination effects with either extract appeared to be antagonistic in the case of gemcitabine and additive to mildly synergistic in the case of doxorubicin. Both SPES and PC-SPES exhibited significant toxicity in pancreatic cancer cells, mediated via induction of apoptosis. Both mixtures should be evaluated for their in vivo and clinical therapeutic utility as monotherapy agents against pancreatic cancer. SPES could possibly be combined with cell cycle-independent cytotoxic drugs. Due to a consistent G2 blocking pattern, PC-SPES may prove useful as a radiation sensitizer.",
keywords = "Chinese herbal supplements, Combination toxicity, Pancreatic cancer, PC-SPES, SPES, Synergism",
author = "Schwarz, {Roderich E.} and Donohue, {Cecile A.} and David Sadava and Kane, {Susan E.}",
year = "2003",
month = "1",
day = "10",
doi = "10.1016/S0304-3835(02)00501-3",
language = "English (US)",
volume = "189",
pages = "59--68",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES

T2 - Implications for monotherapy and combination treatment

AU - Schwarz, Roderich E.

AU - Donohue, Cecile A.

AU - Sadava, David

AU - Kane, Susan E.

PY - 2003/1/10

Y1 - 2003/1/10

N2 - One of the greatest challenges in the treatment of pancreatic cancer remains its inherent lack of beneficial response to cytotoxic chemotherapy. Chinese herbal extracts have been widely used for the treatment of various cancers, but objective information on their efficacy in pancreatic cancer is lacking. Eight human pancreatic cancer cell lines (MIA, Panc-1, BxPC, ASPC, HS-766T, CaPan-2, CFPAC, and HTB-147) were studied for in vitro susceptibility to ethanol extracts of SPES and PC-SPES, two quality-controlled, dried, encapsulated supplements of 15 and eight Chinese herbs, respectively. Resulting toxicities, alone and in combination with doxorubicin or gemcitabine, were analyzed by [3H]thymidine incorporation or sulforhodamine B staining, colony formation, and TUNEL flow cytometry assays. Combination toxicity mechanisms were calculated by the combination index method of Chou and Talalay. In all cell lines, there was dose-dependent inhibition of proliferation. By [3H]thymidine incorporation assay, 50% growth inhibition after 48 h continuous exposure (IC50) occurred at concentrations of 0.2-0.8 μl/ml SPES and 0.4-1.3 μl/ml PC-SPES. Growth inhibition was accompanied by a significant enhancement of the TUNEL-positive apoptotic fraction of all cell lines after treatment with either extract. After treatment with PC-SPES, the cell lines consistently displayed a G2 cell cycle block; SPES induced an increase in S phase, with a smaller impact on G2. When added at a concentration of 0.2 μl/ml (∼IC20), both extracts enhanced Panc-1 cell killing mediated by doxorubicin, with an average decrease in the corresponding IC50 of 33% (range 11-62%). Combination effects with either extract appeared to be antagonistic in the case of gemcitabine and additive to mildly synergistic in the case of doxorubicin. Both SPES and PC-SPES exhibited significant toxicity in pancreatic cancer cells, mediated via induction of apoptosis. Both mixtures should be evaluated for their in vivo and clinical therapeutic utility as monotherapy agents against pancreatic cancer. SPES could possibly be combined with cell cycle-independent cytotoxic drugs. Due to a consistent G2 blocking pattern, PC-SPES may prove useful as a radiation sensitizer.

AB - One of the greatest challenges in the treatment of pancreatic cancer remains its inherent lack of beneficial response to cytotoxic chemotherapy. Chinese herbal extracts have been widely used for the treatment of various cancers, but objective information on their efficacy in pancreatic cancer is lacking. Eight human pancreatic cancer cell lines (MIA, Panc-1, BxPC, ASPC, HS-766T, CaPan-2, CFPAC, and HTB-147) were studied for in vitro susceptibility to ethanol extracts of SPES and PC-SPES, two quality-controlled, dried, encapsulated supplements of 15 and eight Chinese herbs, respectively. Resulting toxicities, alone and in combination with doxorubicin or gemcitabine, were analyzed by [3H]thymidine incorporation or sulforhodamine B staining, colony formation, and TUNEL flow cytometry assays. Combination toxicity mechanisms were calculated by the combination index method of Chou and Talalay. In all cell lines, there was dose-dependent inhibition of proliferation. By [3H]thymidine incorporation assay, 50% growth inhibition after 48 h continuous exposure (IC50) occurred at concentrations of 0.2-0.8 μl/ml SPES and 0.4-1.3 μl/ml PC-SPES. Growth inhibition was accompanied by a significant enhancement of the TUNEL-positive apoptotic fraction of all cell lines after treatment with either extract. After treatment with PC-SPES, the cell lines consistently displayed a G2 cell cycle block; SPES induced an increase in S phase, with a smaller impact on G2. When added at a concentration of 0.2 μl/ml (∼IC20), both extracts enhanced Panc-1 cell killing mediated by doxorubicin, with an average decrease in the corresponding IC50 of 33% (range 11-62%). Combination effects with either extract appeared to be antagonistic in the case of gemcitabine and additive to mildly synergistic in the case of doxorubicin. Both SPES and PC-SPES exhibited significant toxicity in pancreatic cancer cells, mediated via induction of apoptosis. Both mixtures should be evaluated for their in vivo and clinical therapeutic utility as monotherapy agents against pancreatic cancer. SPES could possibly be combined with cell cycle-independent cytotoxic drugs. Due to a consistent G2 blocking pattern, PC-SPES may prove useful as a radiation sensitizer.

KW - Chinese herbal supplements

KW - Combination toxicity

KW - Pancreatic cancer

KW - PC-SPES

KW - SPES

KW - Synergism

UR - http://www.scopus.com/inward/record.url?scp=0037427567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037427567&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(02)00501-3

DO - 10.1016/S0304-3835(02)00501-3

M3 - Article

C2 - 12445678

AN - SCOPUS:0037427567

VL - 189

SP - 59

EP - 68

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -